Table 3 Association between cardiovascular health metrics and the risk of nonalcoholic fatty liver disease
Cardiovascular health metrics | No. of people | NAFLD by fatty liver index | NAFLD by liver-to-spleen ratio | ||||
|---|---|---|---|---|---|---|---|
No. (%) of people with NAFLD | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | No. (%) of people with NAFLD | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | ||
Category (score) | |||||||
 Poor (0–7) | 494 | 344 (69.6) | 6.31 (5.08–7.83) | 2.87 (2.13–3.86) | 187 (37.9) | 3.87 (3.10–4.84) | 1.63 (1.24–2.14) |
 Intermediate (8–11) | 1,920 | 512 (26.7) | 1.00 | 1.00 | 261 (13.6) | 1.00 | 1.00 |
 Ideal (12–14) | 514 | 21 (4.1) | 0.12 (0.08–0.18) | 0.13 (0.07–0.23) | 25 (4.9) | 0.33 (0.21–0.50) | 0.55 (0.35–0.86) |
Continuous score, per 1.0 | |||||||
 Overall | 2,928 | 877 (30.0) | 0.52 (0.49–0.55) | 0.63 (0.59–0.68) | 473 (16.2) | 0.66 (0.62–0.69) | 0.83 (0.78–0.89) |
 Behavioral components | 2,928 | 877 (30.0) | 0.52 (0.49–0.56) | 0.55 (0.50–0.60) | 473 (16.2) | 0.68 (0.64–0.73) | 0.86 (0.79–0.93) |
 Biomarker components | 2,928 | 877 (30.0) | 0.52 (0.48–0.56) | 0.77 (0.69–0.87) | 473 (16.2) | 0.56 (0.52–0.61) | 0.77 (0.69–0.86) |